CompletedPhase 1NCT02256618

Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

Studying Neonatal hypoxic and ischemic brain injury

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Neonatal Encephalopathy Consortium, Japan
Principal Investigator
Haruo Shintaku, MD, PhD, D.C
Osaka City University
Intervention
Autologous umbilical cord blood cells(other)
Enrollment
6 enrolled
Eligibility
All sexes
Timeline
20142019

Study locations (6)

Collaborators

Osaka City University · Yodogawa Christian Hospital · Kurashiki Central Hospital · Nagoya University · Osaka City General Hospital · Saitama Medical University · National Cerebral and Cardiovascular Center, Japan · National Center for Child Health and Development, Japan · Tokyo University · Tokyo Women's Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02256618 on ClinicalTrials.gov

Other trials for Neonatal hypoxic and ischemic brain injury

Additional recruiting or active studies for the same condition.

See all trials for Neonatal hypoxic and ischemic brain injury

← Back to all trials